Holen Sie sich die Stockscreener-App
104.57
2.83%
2.88
Handel nachbörslich:
104.57
Schlusskurs vom Vortag:
$101.69
Offen:
$101.47
24-Stunden-Volumen:
562.16K
Relative Volume:
0.81
Marktkapitalisierung:
$6.95B
Einnahmen:
$136.86M
Nettoeinkommen (Verlust:
$-168.69M
KGV:
-37.21
EPS:
-2.81
Netto-Cashflow:
$-113.49M
1W Leistung:
+0.33%
1M Leistung:
+15.88%
6M Leistung:
+96.49%
1J Leistung:
+123.01%
1-Tages-Spanne:
$101.47
$104.57
1-Wochen-Bereich:
$101.45
$106.52
52-Wochen-Spanne:
$45.91
$106.52
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
Firmenname
Rhythm Pharmaceuticals Inc
Sektor
Branche
Telefon
857-264-4280
Adresse
222 BERKELEY STREET, BOSTON, MA
Vergleichen Sie RYTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
104.57 | 6.92B | 136.86M | -168.69M | -113.49M | -2.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-07-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-03-05 | Fortgesetzt | Stifel | Buy |
| 2025-01-02 | Eingeleitet | Jefferies | Buy |
| 2024-12-20 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Guggenheim | Buy |
| 2024-09-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-17 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-01 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-18 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-08-08 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-06-17 | Bestätigt | Needham | Buy |
| 2022-03-02 | Fortgesetzt | Stifel | Buy |
| 2022-02-17 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-14 | Fortgesetzt | Goldman | Neutral |
| 2021-08-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-08-04 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-08 | Eingeleitet | Goldman | Sell |
| 2019-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-07-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-03-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-09-07 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-06-25 | Bestätigt | Needham | Buy |
| 2018-06-15 | Bestätigt | Needham | Buy |
| 2017-10-30 | Eingeleitet | BofA/Merrill | Buy |
| 2017-10-30 | Eingeleitet | Needham | Buy |
Alle ansehen
Rhythm Pharmaceuticals Inc Aktie (RYTM) Neueste Nachrichten
Visual trend scoring systems applied to Rhythm Pharmaceuticals Inc.Quarterly Trade Review & Short-Term High Return Strategies - Newser
Using Bollinger Bands to evaluate Rhythm Pharmaceuticals Inc.July 2025 Highlights & Fast Entry High Yield Tips - Newser
What moving averages say about Rhythm Pharmaceuticals Inc.Market Risk Analysis & Consistent Profit Trading Strategies - Newser
Comparing Rhythm Pharmaceuticals Inc. in custom built stock radars2025 Bull vs Bear & Consistent Return Investment Signals - Newser
Reversal indicators forming on Rhythm Pharmaceuticals Inc. stockEarnings Risk Report & Consistent Profit Focused Trading Strategies - Newser
What earnings revisions data tells us about Rhythm Pharmaceuticals Inc.Quarterly Earnings Report & Verified Trade Idea Suggestions - Newser
Statistical indicators supporting Rhythm Pharmaceuticals Inc.’s strengthEarnings Risk Summary & Smart Swing Trading Alerts - Newser
Rhythm Pharmaceuticals Inc. stock outlook for YEAR2025 Growth vs Value & AI Based Buy/Sell Signal Reports - Newser
Applying Wyckoff theory to Rhythm Pharmaceuticals Inc. stockJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser
Signal strength of Rhythm Pharmaceuticals Inc. stock in tech scannersPortfolio Update Report & Long-Term Safe Investment Plans - Newser
Aug Action: Is Rhythm Pharmaceuticals Inc. a speculative investmentPortfolio Performance Report & Consistent Profit Trade Alerts - khodrobank.com
Applying big data sentiment scoring on Rhythm Pharmaceuticals Inc.2025 Key Highlights & Stepwise Swing Trade Plans - Newser
Can Rhythm Pharmaceuticals Inc. recover in the next quarterMarket Performance Summary & Community Consensus Picks - Newser
Backtesting results for Rhythm Pharmaceuticals Inc. trading strategiesEarnings Performance Report & Stepwise Entry and Exit Trade Signals - Newser
Risk adjusted return profile for Rhythm Pharmaceuticals Inc. analyzedTrade Performance Summary & Consistent Income Trade Ideas - Newser
Citizens JMP Keeps Market Outperform Rating on Rhythm Pharmaceuticals (RYTM) - MSN
Custom strategy builders for tracking Rhythm Pharmaceuticals Inc.Jobs Report & Growth Oriented Trading Recommendations - Newser
Can Rhythm Pharmaceuticals Inc. rally from current levels2025 EndofYear Setup & Risk Adjusted Swing Trade Ideas - Newser
Published on: 2025-09-02 04:29:59 - Newser
Can Rhythm Pharmaceuticals Inc. expand into new marketsMarket Risk Report & Risk Controlled Stock Pick Alerts - khodrobank.com
Combining machine learning predictions for Rhythm Pharmaceuticals Inc.Dividend Hike & Momentum Based Trading Ideas - Newser
Why Rhythm Pharmaceuticals Inc. stock is on top investor watchlists2025 Pullback Review & Low Risk Growth Stock Ideas - Newser
Is Rhythm Pharmaceuticals Inc. currently under institutional pressureJuly 2025 News Drivers & Weekly High Return Opportunities - khodrobank.com
Can Rhythm Pharmaceuticals Inc. outperform under higher oil prices2025 Geopolitical Influence & Reliable Price Breakout Alerts - khodrobank.com
Is this a good reentry point in Rhythm Pharmaceuticals Inc.2025 Key Lessons & Technical Pattern Based Signals - Newser
Will Rhythm Pharmaceuticals Inc. benefit from rising consumer demandWeekly Trend Recap & Community Consensus Picks - khodrobank.com
Is This the Dip to Buy in Rhythm Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
When is the best time to exit Rhythm Pharmaceuticals Inc.Insider Selling & Long-Term Capital Growth Ideas - Newser
Is Rhythm Pharmaceuticals Inc. forming a reversal patternQuarterly Trade Summary & AI Powered Market Entry Ideas - Newser
Rhythm Pharmaceuticals Inc. Breaks Losing Streak — Is the Trend ReversingMarket Trend Review & Weekly Breakout Watchlists - beatles.ru
What MACD and RSI say about Rhythm Pharmaceuticals Inc.Trade Entry Summary & High Accuracy Trade Alerts - Newser
How to use a screener to detect Rhythm Pharmaceuticals Inc. breakoutsJuly 2025 Market Mood & Reliable Entry Point Alerts - Newser
Chart based analysis of Rhythm Pharmaceuticals Inc. trendsJuly 2025 Recap & Capital Efficiency Focused Ideas - Newser
Finanzdaten der Rhythm Pharmaceuticals Inc-Aktie (RYTM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rhythm Pharmaceuticals Inc-Aktie (RYTM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Shulman Joseph | Chief Technical Officer |
Aug 21 '25 |
Option Exercise |
27.35 |
4,188 |
114,542 |
12,697 |
| Shulman Joseph | Chief Technical Officer |
Aug 21 '25 |
Sale |
100.07 |
4,188 |
419,091 |
8,509 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):